Bei Jing Shang Bao·2025-12-01 12:44Core Viewpoint - The company announced the completion of the deregistration of its subsidiary, Hubei Zhixin Biotechnology Co., Ltd., as part of a strategic move to optimize its organizational structure and improve operational efficiency [1] Group 1: Company Actions - The subsidiary, Hubei Zhixin Biotechnology Co., Ltd., was established on May 22, 2017, with a registered capital of 600,000 RMB [1] - The decision to deregister was approved during a board and supervisory meeting held on October 24, 2024, with the announcement made on October 25 [1] - The deregistration process was confirmed by the Yichang High-tech Zone Market Supervision Administration through a notification letter [1] Group 2: Business Strategy - The deregistration is aimed at resource integration, organizational optimization, reduction of management costs, and enhancement of management efficiency and operational effectiveness [1]